SCHEDULE 13G/A

Contineum Therapeutics Inc

Class A Common Stock, par value $0.001 per share · CUSIP: 21217B100

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Perceptive Advisors LLC

  Shares: 1,441,249 · Class: 7.5%

• Joseph Edelman

  Shares: 1,441,249 · Class: 7.5%

• Perceptive Life Sciences Master Fund, Ltd.

  Shares: 1,441,249 · Class: 7.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.